Neural Therapeutics Inc. (CSE:NURL)
0.0400
0.00 (0.00%)
At close: Apr 25, 2025
Neural Therapeutics Statistics
Total Valuation
CSE:NURL has a market cap or net worth of CAD 3.55 million. The enterprise value is 3.72 million.
Market Cap | 3.55M |
Enterprise Value | 3.72M |
Important Dates
The last earnings date was Tuesday, April 1, 2025.
Earnings Date | Apr 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:NURL has 88.70 million shares outstanding. The number of shares has increased by 31.99% in one year.
Current Share Class | n/a |
Shares Outstanding | 88.70M |
Shares Change (YoY) | +31.99% |
Shares Change (QoQ) | +1.15% |
Owned by Insiders (%) | 0.83% |
Owned by Institutions (%) | 13.63% |
Float | 87.96M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -8.09 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -6.79 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92
Current Ratio | 1.92 |
Quick Ratio | 1.92 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -102.00% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -196.90% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 60.32 |
Average Volume (20 Days) | 85,614 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -527,608 |
Pretax Income | -548,147 |
Net Income | -548,147 |
EBITDA | n/a |
EBIT | -527,608 |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 546,318 in cash and 718,555 in debt, giving a net cash position of -172,237 or -0.00 per share.
Cash & Cash Equivalents | 546,318 |
Total Debt | 718,555 |
Net Cash | -172,237 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | -438,706 |
Book Value Per Share | -0.01 |
Working Capital | 267,964 |
Cash Flow
Operating Cash Flow | -77,836 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:NURL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -31.99% |
Shareholder Yield | -31.99% |
Earnings Yield | -15.45% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |